Share Email Print

Proceedings Paper

Comparison of meso-tetrahydroxyphenyl-chlorin and meso-tetrahydroxyphenyl-bacteriochlorin with respect to photobleaching and PCT efficiency in vivo
Author(s): Li Wei Ma; Johan Moan; Michael F. Grahn; Vladimir Iani
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Using BALB/c nude mice bearing WiDr human colon adenocarcinoma, we investigated photobleaching and photochemotherapeutic (PCT) effects of meso- tetrahydroxyphenyl-chlorin (mTHPC) and meso- tetrahydroxyphenyl-bacteroiochlorin (mTHPBC). For both studies, mice were injected i.p. 1 mg/kg mTHPC and mTHPBC, respectively, 24 hr before light irradiation. Photobleaching of the sensitizers in mouse skin was carried out using a dye laser (for mTHPC) and 1 KW xenon source equipped with a monochromator (for mTHPBC). Fluorescence measurements were made by means of a fiberoptic system, exciting and collecting the fluorescence from the mouse skin. The system was coupled to a PE L550 fluorimeter. For the PCT study, the mTHPC or mTHPBC-sensitized tumors were exposed to the laser at a fluence of 10 J/cm2. The responses of the treated tumors were evaluated by measuring the tumor growth. We found that both mTHPC and mTHPBC are photolabile. Approximately 80% of the fluorescence of the two dyes in the mouse skin is bleached by a fluence of 10 J/cm2. When mTHPBC in mouse skin was photobleached by light of 740 nm, the bacteriochlorin (peak at 740 nm) was significantly bleached while the chlorin (peak at 652 nm) was unaffected. The growth of the tumors was delayed by 13 days after PCT with 1 mg/kg mTHPC Irradiation at 652 nm) and 5 days delay after PCT with 1 mg/kg mTHPBC (irradiation at 515 nm). The present data indicate that (1) by proper choice of a low dose of mTHPC or MTHPBC, it is possible to photobleach the sensitizers in normal tissues without eliminating their PCT effect on tumor tissues; (2) in order to increase the efficiency of PCT with mTHPBC, fractionated irradiation with different wavelengths (740 nm and 652 nm) should be considered to be used.

Paper Details

Date Published: 4 December 1996
PDF: 6 pages
Proc. SPIE 2924, Photochemotherapy: Photodynamic Therapy and Other Modalities II, (4 December 1996);
Show Author Affiliations
Li Wei Ma, Institute for Cancer Research (Norway)
Johan Moan, Institute for Cancer Research (Norway)
Michael F. Grahn, Royal London Hospital (United Kingdom)
Vladimir Iani, Institute for Cancer Research (Norway)

Published in SPIE Proceedings Vol. 2924:
Photochemotherapy: Photodynamic Therapy and Other Modalities II
Stanley B. Brown; Benjamin Ehrenberg; Johan Moan, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?